Climate Change Data Portal
DOI | 10.1016/j.aquatox.2017.01.001 |
Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone | |
Davis, J. M.1,3; Ekman, D. R.1; Skelton, D. M.1,4; LaLone, C. A.2; Ankley, G. T.2; Cavallin, J. E.2; Villeneuve, D. L.2; Collette, T. W.1 | |
发表日期 | 2017-03-01 |
ISSN | 0166-445X |
卷号 | 184页码:103-115 |
英文摘要 | One objective in developing adverse outcome pathways (AOPs) is to connect biological changes that are relevant to risk assessors (i.e., fecundity) to molecular and cellular-level alterations that might be detectable at earlier stages of a chemical exposure. Here, we examined biochemical responses of fathead minnows (Pimephales promelas) to inform an AOP relevant to spironolactone's activation of the androgen receptor, as well as explore other biological impacts possibly unrelated to this receptor. Liquid chromatography with high resolution mass spectrometry (LC-MS) was used to measure changes in endogenous polar metabolites in livers of male and female fish that were exposed to five water concentrations of spironolactone (0, 0.05, 0.5. 5, or 50 mu g L-1) for 21 days. Metabolite profiles were affected at the two highest concentrations (5 and 50 mu g L-1), but not in the lower-level exposures, which agreed with earlier reported results of reduced female fecundity and plasma vitellogenin (VTG) levels. We then applied partial least squares regression to assess whether metabolite alterations covaried with changes in fecundity, VTG gene expression and protein concentrations, and plasma 17 beta-estradiol and testosterone concentrations. Metabolite profiles significantly covaried with all measured endpoints in females, but only with plasma testosterone in males. Fecundity reductions occurred in parallel with changes in metabolites important in osmoregulation (e.g., betaine), membrane transport (e.g., L-carnitine), and biosynthesis of carnitine (e.g., methionine) and VTG (e.g., glutamate). Based on a network analysis program (i.e., mummichog), spironolactone also affected amino acid, tryptophan, and fatty acid metabolism. Thus, by identifying possible key events related to changes in biochemical pathways, this approach built upon an established AOP describing spirono-lactone's androgenic properties and highlighted broader implications potentially unrelated to androgen receptor activation, which could form a basis for the development of an AOP network. Published by Elsevier B.V. |
英文关键词 | Metabolomics;Fathead minnow;Mineralocorticoid;Reproduction |
语种 | 英语 |
WOS记录号 | WOS:000395608900009 |
来源期刊 | AQUATIC TOXICOLOGY
![]() |
来源机构 | 美国环保署 |
文献类型 | 期刊论文 |
条目标识符 | http://gcip.llas.ac.cn/handle/2XKMVOVA/57798 |
作者单位 | 1.US EPA, Natl Exposure Res Lab, 960 Coll Stn Rd, Athens, GA 30605 USA; 2.US EPA, Natl Hlth & Environm Effects Res Lab, 6201 Congdon Blvd, Duluth, MN 55804 USA; 3.US EPA, Water Protect Div, Reg 4,61 Forsyth St SW, Atlanta, GA 30303 USA; 4.US FDA, 6751 Steger Dr, Cincinnati, OH 45237 USA |
推荐引用方式 GB/T 7714 | Davis, J. M.,Ekman, D. R.,Skelton, D. M.,et al. Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone[J]. 美国环保署,2017,184:103-115. |
APA | Davis, J. M..,Ekman, D. R..,Skelton, D. M..,LaLone, C. A..,Ankley, G. T..,...&Collette, T. W..(2017).Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone.AQUATIC TOXICOLOGY,184,103-115. |
MLA | Davis, J. M.,et al."Metabolomics for informing adverse outcome pathways: Androgen receptor activation and the pharmaceutical spironolactone".AQUATIC TOXICOLOGY 184(2017):103-115. |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。